158 related articles for article (PubMed ID: 16086597)
21. Rational dosing of antimicrobial agents: pharmacokinetic and pharmacodynamic strategies.
Owens RC; Shorr AF
Am J Health Syst Pharm; 2009 Jun; 66(12 Suppl 4):S23-30. PubMed ID: 19502225
[TBL] [Abstract][Full Text] [Related]
22. Guidelines-concordant empiric antimicrobial therapy and mortality in patients with severe community-acquired pneumonia requiring mechanical ventilation.
Sakamoto Y; Yamauchi Y; Yasunaga H; Takeshima H; Hasegawa W; Jo T; Matsui H; Fushimi K; Nagase T
Respir Investig; 2017 Jan; 55(1):39-44. PubMed ID: 28012492
[TBL] [Abstract][Full Text] [Related]
23. Treating paediatric community-acquired pneumonia in the era of antimicrobial resistance.
Galli L; Montagnani C; Chiappini E; de Martino M
Acta Paediatr; 2013 Dec; 102(465):25-33. PubMed ID: 24330270
[TBL] [Abstract][Full Text] [Related]
24. Optimal pharmacological therapy for community-acquired pneumonia: the role of dual antibacterial therapy.
Epstein BJ; Gums JG
Drugs; 2005; 65(14):1949-71. PubMed ID: 16162020
[TBL] [Abstract][Full Text] [Related]
25. Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia.
Avdic E; Cushinotto LA; Hughes AH; Hansen AR; Efird LE; Bartlett JG; Cosgrove SE
Clin Infect Dis; 2012 Jun; 54(11):1581-7. PubMed ID: 22495073
[TBL] [Abstract][Full Text] [Related]
26. Value of short-course antimicrobial therapy in community-acquired pneumonia.
Blasi F; Tarsia P
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 3():S148-55. PubMed ID: 16543076
[TBL] [Abstract][Full Text] [Related]
27. Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians.
Lee RA; Centor RM; Humphrey LL; Jokela JA; Andrews R; Qaseem A; ; Akl EA; Bledsoe TA; Forciea MA; Haeme R; Kansagara DL; Marcucci M; Miller MC; Obley AJ
Ann Intern Med; 2021 Jun; 174(6):822-827. PubMed ID: 33819054
[TBL] [Abstract][Full Text] [Related]
28. Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months.
Lassi ZS; Imdad A; Bhutta ZA
Cochrane Database Syst Rev; 2015 Jun; (6):CD008032. PubMed ID: 26077639
[TBL] [Abstract][Full Text] [Related]
29. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months.
Haider BA; Saeed MA; Bhutta ZA
Cochrane Database Syst Rev; 2008 Apr; (2):CD005976. PubMed ID: 18425930
[TBL] [Abstract][Full Text] [Related]
30. Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial.
Greenberg D; Givon-Lavi N; Sadaka Y; Ben-Shimol S; Bar-Ziv J; Dagan R
Pediatr Infect Dis J; 2014 Feb; 33(2):136-42. PubMed ID: 23989106
[TBL] [Abstract][Full Text] [Related]
31. A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia.
Foolad F; Huang AM; Nguyen CT; Colyer L; Lim M; Grieger J; Li J; Revolinski S; Mack M; Gandhi T; Wainaina JN; Eschenauer G; Patel TS; Marshall VD; Nagel J
J Antimicrob Chemother; 2018 May; 73(5):1402-1407. PubMed ID: 29462306
[TBL] [Abstract][Full Text] [Related]
32. Community-acquired pneumonia.
Cassiere HA; Niederman MS
Dis Mon; 1998 Nov; 44(11):613-75. PubMed ID: 9858958
[TBL] [Abstract][Full Text] [Related]
33. Appropriate outpatient macrolide use in community-acquired pneumonia.
Gotfried MH
J Am Acad Nurse Pract; 2004 Apr; 16(4):146, 148, 150 passim. PubMed ID: 15137473
[TBL] [Abstract][Full Text] [Related]
34. Evidence-based medicine: empiric antibiotic therapy in community-acquired pneumonia.
Read RC
J Infect; 1999 Nov; 39(3):171-8. PubMed ID: 10714789
[TBL] [Abstract][Full Text] [Related]
35. [Short course antibiotic treatment during community acquired pneumonia: Review of the literature and perspectives].
Philippot Q; Dinh A; Voiriot G
Rev Mal Respir; 2020 Jan; 37(1):26-33. PubMed ID: 31883818
[TBL] [Abstract][Full Text] [Related]
36. [Updated acute community-acquired pneumonia in adults: Guidelines for initial antimicrobial therapy based on local evidence from the South American Working Group (ConsenSur II)].
Bantar C; Curcio D; Jasovich A; Bagnulo H; Arango A; Bavestrello L; Famiglietti A; García P; Lopardo G; Losanovscky M; Martínez E; Pedreira W; Piñeyro L; Remolif C; Rossi F; Varón F
Rev Chilena Infectol; 2010 Jun; 27 Suppl 1():S9-S38. PubMed ID: 20737129
[TBL] [Abstract][Full Text] [Related]
37. Principles of Antibiotic Management of Community-Acquired Pneumonia.
Bender MT; Niederman MS
Semin Respir Crit Care Med; 2016 Dec; 37(6):905-912. PubMed ID: 27960214
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review.
Mathur S; Fuchs A; Bielicki J; Van Den Anker J; Sharland M
Paediatr Int Child Health; 2018 Nov; 38(sup1):S66-S75. PubMed ID: 29790844
[TBL] [Abstract][Full Text] [Related]
39. Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistance.
Kuti JL; Capitano B; Nicolau DP
Pharmacoeconomics; 2002; 20(8):513-28. PubMed ID: 12109917
[TBL] [Abstract][Full Text] [Related]
40. Acute community-acquired pneumonia in adults: guidelines for initial antimicrobial therapy based on local evidence from a South American Working Group (ConsenSur).
Bantar C; Bavestrello L; Curcio D; Jasovich A; Absi R; Bagnulo H; Famiglietti A; García P; Labarca J; Mera J; Pedreira W; Sader H; Thompson L; Wey S;
J Chemother; 2002 Dec; 14 Suppl 4():1-22. PubMed ID: 12680511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
